Earnings Call · Q2 FY2026·2026-08-12

Q2 26EPS +13.48%·Rev n/aQ1 26EPS +8.35%·Rev n/aQ4 25EPS -87.76%·Rev n/aQ3 25EPS -25.00%·Rev n/a⚠ consensus missing

Kura Oncology, Inc. KURA

Linnaeus — Conference Operator

Greg Mann — Senior Vice President, Investor Relations and Corporate Affairs

Dr. Troy Wilson — President and Chief Executive Officer

Brian Powl — Chief Commercial Officer

Dr. Mollie Leoni — Chief Medical Officer

Tom Doyle — Senior Vice President, Finance and Accounting

+1.5%1d on move date3d+13.5%5d+26.1%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KURA calls or request research access.

More KURA calls Browse calls Request research access